ATE256184T1 - Promotor des utrophingens - Google Patents

Promotor des utrophingens

Info

Publication number
ATE256184T1
ATE256184T1 AT96911038T AT96911038T ATE256184T1 AT E256184 T1 ATE256184 T1 AT E256184T1 AT 96911038 T AT96911038 T AT 96911038T AT 96911038 T AT96911038 T AT 96911038T AT E256184 T1 ATE256184 T1 AT E256184T1
Authority
AT
Austria
Prior art keywords
pct
promoter
utrophin
date oct
sec
Prior art date
Application number
AT96911038T
Other languages
English (en)
Inventor
Jonathon Mark Tinsley
Kay Elizabeth Davies
Carina Dennis
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508236.8A external-priority patent/GB9508236D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE256184T1 publication Critical patent/ATE256184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C07K14/4708—Duchenne dystrophy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96911038T 1995-04-24 1996-04-24 Promotor des utrophingens ATE256184T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508236.8A GB9508236D0 (en) 1995-04-24 1995-04-24 Promoting gene expression
GBGB9526028.7A GB9526028D0 (en) 1995-04-24 1995-12-20 Promoting gene expression
PCT/GB1996/000979 WO1996034101A1 (en) 1995-04-24 1996-04-24 Utrophin gene promoter

Publications (1)

Publication Number Publication Date
ATE256184T1 true ATE256184T1 (de) 2003-12-15

Family

ID=26306918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96911038T ATE256184T1 (de) 1995-04-24 1996-04-24 Promotor des utrophingens

Country Status (7)

Country Link
US (1) US5972609A (de)
EP (1) EP0824589B1 (de)
JP (1) JP4364941B2 (de)
AT (1) ATE256184T1 (de)
AU (1) AU712450B2 (de)
DE (1) DE69631041T2 (de)
WO (1) WO1996034101A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306903B1 (en) 1995-07-26 2007-12-11 Curis, Inc. Methods and compositions for identifying morphogen analogs
US6103491A (en) * 1995-07-26 2000-08-15 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US6090544A (en) * 1995-07-26 2000-07-18 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6911307B1 (en) * 1998-12-08 2005-06-28 Proteus S.A. Method of detection in vitro of a target substance in a sample comprising the labelling of said substance with a reporter gene and with the sequences necessary for the expression of said reporter gene in vitro
GB9923423D0 (en) * 1999-10-04 1999-12-08 Isis Innovation Promoting gene expression
WO2002036620A2 (en) * 2000-11-02 2002-05-10 Myocontract Ag Ets-transcription factor related compound specific promoter and transactivators thereof
WO2009045370A2 (en) 2007-09-28 2009-04-09 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Also Published As

Publication number Publication date
US5972609A (en) 1999-10-26
DE69631041T2 (de) 2004-09-02
AU712450B2 (en) 1999-11-04
AU5404396A (en) 1996-11-18
JPH11504515A (ja) 1999-04-27
WO1996034101A1 (en) 1996-10-31
DE69631041D1 (de) 2004-01-22
JP4364941B2 (ja) 2009-11-18
EP0824589A1 (de) 1998-02-25
EP0824589B1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
Nissen et al. Molecular analysis of the transcriptional regulatory region of an early baculovirus gene
Nordqvist et al. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs
Frankel et al. Cellular uptake of the tat protein from human immunodeficiency virus
Abeles et al. P1 plasmid replication: replicon structure
Jones et al. Control of gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Multiple dioxin-responsive domains 5'-ward of the cytochrome P1-450 gene.
US5358857A (en) Method of preparing fusion proteins
Hess et al. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation
Meyuhas et al. The mouse ribosomal protein L7 gene. Its primary structure and functional analysis of the promoter region.
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
Widen et al. Liver-specific expression of the mouse alpha-fetoprotein gene is mediated by cis-acting DNA elements.
CA2205874A1 (en) Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
IL114820A0 (en) Method for selecting high-expressing host cells
DE69636032D1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
Hwung et al. Cooperativity of sequence elements mediates tissue specificity of the rat insulin II gene
DE69631041D1 (de) Promotor des utrophingens
AU7617796A (en) Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability
Albright et al. Identification of a gene linked to Rhizobium meliloti ntrA whose product is homologous to a family to ATP-binding proteins
ATE417114T1 (de) Promotor des utrophingens
Larsson et al. VA RNAs from avian and human adenoviruses: dramatic differences in length, sequence, and gene location
Hoffman et al. The ovarian, ecdysterone, and heat-shock-responsive promoters of the Drosophila melanogaster hsp27 gene react very differently to perturbations of DNA sequence
Milton et al. In vitro mutagenesis and overexpression of the Escherichia coli trpA gene and the partial characterization of the resultant tryptophan synthase mutant alpha-subunits.
Ivanov et al. Chemical synthesis and expression of the human calcitonin gene
Bourdineaud et al. Characterization of the arcD arginine: ornithine exchanger of Pseudomonas aeruginosa. Localization in the cytoplasmic membrane and a topological model.
JO1694B1 (en) New chemical products
FR2717694B1 (fr) Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824589

Country of ref document: EP

REN Ceased due to non-payment of the annual fee